Artículos por temáticas

[Depression in Parkinson's disease].

Kitamura S, Nagayama H.

Seishin Shinkeigaku Zasshi. 2013;115(11):1135-41. Review. Japanese.

[Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia].

Niccoli Asabella A, Ruggeri M, Rubini D, Polimeno L, Spinelli C, Polito M, Pennelli M, Altini C, De Caro MS, Defazio G, Rubini G.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):393-7. doi: 10.1701/1315.14582. Italian.

Transcranial sonography on Parkinson's disease and essential tremor.

Chitsaz A, Mehrbod N, Saadatnia M, Fereidan-Esfahani M, Akbari M, Abtahi SH.

J Res Med Sci. 2013 Mar;18(Suppl 1):S28-31.

Autoimmunity, dendritic cells and relevance for Parkinson's disease.

Koutsilieri E, Lutz MB, Scheller C.

J Neural Transm (Vienna). 2013 Jan;120(1):75-81. doi: 10.1007/s00702-012-0842-7. Review.

Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in ho

Brenner SR.

Med Hypotheses. 2013 Jan;80(1):103. doi: 10.1016/j.mehy.2012.10.010. No abstract available.

New synaptic and molecular targets for neuroprotection in Parkinson's disease.

Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM.

Mov Disord. 2013 Jan;28(1):51-60. doi: 10.1002/mds.25096. Review.

How precise are activities of daily living scales for the diagnosis of Parkinson's disease dementia? A pilot study.

Christ JB, Fruhmann Berger M, Riedl E, Prakash D, Csoti I, Molt W, Gräber S, Brockmann K, Berg D, Liepelt-Scarfone I.

Parkinsonism Relat Disord. 2013 Mar;19(3):371-4. doi: 10.1016/j.parkreldis.2012.11.004.

Long-term statin use and the risk of Parkinson's disease.

Friedman B, Lahad A, Dresner Y, Vinker S.

Am J Manag Care. 2013 Aug;19(8):626-32.

Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis.

Liu X, Ma T, Qu B, Ji Y, Liu Z.

Genet Test Mol Biomarkers. 2013 Nov;17(11):826-32. doi: 10.1089/gtmb.2013.0313.

The differential yet concurrent contributions of motor, cognitive and affective disturbance to freezing of gait in Parkinson's disease.

Shine JM, Naismith SL, Lewis SJ.

Clin Neurol Neurosurg. 2013 May;115(5):542-5. doi: 10.1016/j.clineuro.2012.06.027.

Restless legs syndrome and its associated risk factors in Parkinson's disease.

Azmin S, Khairul Anuar AM, Nafisah WY, Tan HJ, Raymond AA, Hanita O, Shah SA, Norlinah MI.

Parkinsons Dis. 2013;2013:535613. doi: 10.1155/2013/535613.

Parkinson's disease and history of outdoor occupation.

Kwon E, Gallagher LG, Searles Nielsen S, Franklin GM, Littell CT, Longstreth WT Jr, Swanson PD, Checkoway H.

Parkinsonism Relat Disord. 2013 Dec;19(12):1164-6. doi: 10.1016/j.parkreldis.2013.08.014.

Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease.

Brocker DT, Swan BD, Turner DA, Gross RE, Tatter SB, Koop MM, Bronte-Stewart H, Grill WM.

Exp Neurol. 2013 Jan;239:60-7. doi: 10.1016/j.expneurol.2012.09.008.

Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.

Mollenhauer B, Trautmann E, Taylor P, Manninger P, Sixel-Döring F, Ebentheuer J, Trenkwalder C, Schlossmacher MG.

Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004.

Homocysteine and vitamin B12 levels related to MRI white matter abnormalities in Parkinson's disease dementia.

Ozcan O, Cosar A.

Neurodegener Dis. 2013;12(3):164. doi: 10.1159/000345414. No abstract available.